Radiation Exposure of Contrast-Enhanced Spectral Mammography Compared With Full-Field Digital Mammography

Jeukens, Cécile R. L. P. N.; Lalji, Ulrich; Meijer, E.J.; Bakija, Betina; Theunissen, Robin; Wildberger, Joachim E.; Lobbes, Marc

doi:10.1097/rli.0000000000000068

Cited by 95 publications

(51 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nevertheless, CESM cannot substitute MRI in all indications especially in patients with high‐risk of breast cancer (BRCA 1 and 2 carriers), for whom radiation exposure must be limited. Few studies have been published about the extra radiation dose induced by CESM . Fallenberg et al found only 6.2% increase in average glandular dose for CESM compared to MG .…”

Section: Discussionmentioning

confidence: 99%

“…Fallenberg et al found only 6.2% increase in average glandular dose for CESM compared to MG . In a study by Jeukens et al, dose values of both techniques met the recommendations for maximum dose in MG . Francescone et al demonstrated that low‐energy CESM images are equivalent to standard MG, and suggested that low‐energy CESM images may be used for interpretation in place of the MG, thereby reducing patient dose .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment

et al. 2016

View full text Add to dashboard Cite

To assess the value on diagnostic and treatment management of contrast-enhanced spectral mammography (CESM), as adjunct to mammography (MG) and ultrasound (US) in postscreening in a breast cancer unit for patients with newly diagnosed breast cancer or with suspicious findings on conventional imaging. Retrospective review of routine use of bilateral CESM performed between September 2012 and September 2013 in 195 women with suspicious or undetermined findings on MG and/or US. CESM images were blindly reviewed by two radiologists for BI-RADS(®) assessment and probability of malignancy. Each lesion was definitely confirmed either with histopathology or follow-up. Two hundred and ninety-nine lesions were detected (221 malignant). CESM sensitivity, specificity, positive-predictive value and negative-predictive value were 94% (CI: 89-96%), 74% (CI: 63-83%), 91% (CI: 86-94%) and 81% (CI: 70-89%), respectively, with 18 false positive and 14 false negative. CESM changed diagnostic and treatment strategy in 41 (21%) patients either after detection of additional malignant lesions in 38 patients (19%)-with a more extensive surgery (n = 21) or neo-adjuvant chemotherapy (n = 1)-or avoiding further biopsy for 20 patients with negative CESM. CESM can be performed easily in a clinical assessment after positive breast cancer screening and may change significantly the diagnostic and treatment strategy through breast cancer staging.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The average glandular dose (AGD) for a CESM has been reported as between 1.2–1.8 times that of a standard full FFDM and well within the accepted international dose limits for mammography . Fallenburg et al .…”

mentioning

confidence: 53%

Practical uses of contrast‐enhanced spectral mammography in daily work: A pictorial review

et al. 2019

View full text Add to dashboard Cite

Contrast-enhanced spectral mammography (CESM) has a number of uses including the work-up of inconclusive findings on mammography, assessment of breast symptoms, cancer staging, evaluation of response to neoadjuvant chemotherapy and recently as an alternative to magnetic resonance imaging (MRI) in high-risk screening. CESM can be swiftly incorporated into the workflow of busy breast clinics. We share our experiences with CESM at a large breast assessment centre in Western Australia.

show abstract

“…In particular, considering the life attributable risk associated with an AGD value of 1.49 to 1.62 mGy, which is approximately 0.2 cases per 100,000 women aged 40 years, the difference is clinically negligible. 22 Importantly, for all acquisitions, the AGD was below the acceptable limits reported by the European Reference Organization for Quality Assured Breast Screening and Diagnostic Services guidelines. 20,23 Previous studies performed on Hologic Selenia Dimensions DBT systems have published dosimetric patient data for DBT ranging from 1.74 mGy (n = 179) to 2.56 mGy (n = 300), 14-17 which were higher than in the present study (1.49 [0.36] mGy).…”

Section: Discussionmentioning

confidence: 98%

Radiation Exposure of Digital Breast Tomosynthesis Using an Antiscatter Grid Compared With Full-Field Digital Mammography

Paulis¹,

Lobbes²,

Lalji³

et al. 2015

Investigative Radiology

Self Cite

View full text Add to dashboard Cite

show abstract

Radiation Exposure of Contrast-Enhanced Spectral Mammography Compared With Full-Field Digital Mammography

Abstract: Compared with our institutional FFDM, the AGD of a single CESM exposure is increased by 1.25 mGy (+81%), whereas ESAK is increased by 3.07 mGy (+41%). Dose values of both techniques meet the recommendations for maximum dose in mammography.

Cited by 95 publications

References 17 publications

Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment

Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment

Practical uses of contrast‐enhanced spectral mammography in daily work: A pictorial review

Radiation Exposure of Digital Breast Tomosynthesis Using an Antiscatter Grid Compared With Full-Field Digital Mammography

Contact Info

Product

Resources

About